Works matching IS 20406207 AND DT 2019 AND VI 10

Results: 34

Daratumumab in untreated newly diagnosed multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719894871

By:

Abdallah, Nadine;
Kumar, Shaji K.

Publication type:

Article

Biomarkers in acute graft- versus -host disease: new insights.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719891358

By:

Srinagesh, Hrishikesh K.;
Levine, John E.;
Ferrara, James L.M.

Publication type:

Article

Emerging treatment options for patients with p53-pathway-deficient CLL.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719891356

By:

Aitken, Marisa J. L.;
Lee, Hun J.;
Post, Sean M.

Publication type:

Article

Stem-cell transplantation in multiple myeloma: how far have we come?

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719888111

By:

Soekojo, Cinnie Y.;
Kumar, Shaji K.

Publication type:

Article

High factor VIII levels and arterial thrombosis: illustrative case and literature review.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719886685

By:

Algahtani, Farjah Hassan;
Stuckey, Ruth

Publication type:

Article

Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719882822

By:

Richard-Carpentier, Guillaume;
DiNardo, Courtney D.

Publication type:

Article

Allogeneic transplant for FLT3 - ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719882666

By:

Bazarbachi, Abdul Hamid;
Al Hamed, Rama;
Malard, Florent;
Mohty, Mohamad;
Bazarbachi, Ali

Publication type:

Article

Autologous hematopoietic stem-cell transplant in small-sized and peripheral centers: a 10-year experiment.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719879587

By:

Choufi, Bachra;
Alsuliman, Tamim

Publication type:

Article

Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719874733

By:

Economides, Minas P.;
Konopleva, Marina;
Pemmaraju, Naveen

Publication type:

Article

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719874728

By:

Stern, Robert M.;
Connell, Nathan T.

Publication type:

Article

Novel insights into the treatment of complement-mediated hemolytic anemias.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719873321

By:

Berentsen, Sigbjørn;
Hill, Anita;
Hill, Quentin A.;
Tvedt, Tor Henrik Anderson;
Michel, Marc

Publication type:

Article

Updates in the management of polycythemia vera and essential thrombocythemia.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719870052

By:

Bose, Prithviraj;
Verstovsek, Srdan

Publication type:

Article

Insights into novel emerging epigenetic drugs in myeloid malignancies.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719866081

By:

Chandhok, Namrata S.;
Prebet, Thomas

Publication type:

Article

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719861475

By:

Cho, Sung Won;
Franchi, Francesco;
Angiolillo, Dominick J.

Publication type:

Article

Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719860645

By:

Winer, Eric S.;
Stone, Richard M.

Publication type:

Article

Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719860025

By:

Kizilocak, Hande;
Yukhtman, Clara Lana;
Marquez-Casas, Elizabeth;
Lee, Jeanie;
Donkin, Jennifer;
Young, Guy

Publication type:

Article

Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719858471

By:

Lissitchkov, Toshko;
Klukowska, Anna;
Pasi, John;
Kessler, Craig M.;
Klamroth, Robert;
Liesner, Raina J.;
Belyanskaya, Larisa;
Walter, Olaf;
Knaub, Sigurd;
Bichler, Johann;
Jansen, Martina;
Oldenburg, Johannes

Publication type:

Article

Chronic myelomonocytic leukemia associated with myeloid sarcomas and NPM1 mutation: a case report and literature review.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719854596

By:

Matanes, Faris;
AbdelAzeem, Basel M.A.;
Shah, Gaurav;
Reddy, Vishnu;
Saad, Ayman;
Papadantonakis, Nikolaos

Publication type:

Article

Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719854171

By:

Swan, Dawn;
Lynch, Kevin;
Gurney, Mark;
O'Dwyer, Michael

Publication type:

Article

Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719849496

By:

Guerra, Veronica A.;
Jabbour, Elias J.;
Ravandi, Farhad;
Kantarjian, Hagop;
Short, Nicholas J.

Publication type:

Article

Management of myelodysplastic syndromes after failure of response to hypomethylating agents.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719847059

By:

Gil-Perez, Angela;
Montalban-Bravo, Guillermo

Publication type:

Article

Immune targeting of the microenvironment in classical Hodgkin's lymphoma: insights for the hematologist.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719846451

By:

Carreau, Nicole A.;
Diefenbach, Catherine S.

Publication type:

Article

Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719844697

By:

D'Rozario, James;
Bennett, Samuel K.

Publication type:

Article

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719841735

By:

Al-Samkari, Hanny;
Kuter, David J.

Publication type:

Article

The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719841591

By:

Tomassetti, Sarah;
Chen, Robert;
Dandapani, Savita

Publication type:

Article

CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719841581

By:

Chavez, Julio C.;
Bachmeier, Christina;
Kharfan-Dabaja, Mohamed A.

Publication type:

Article

Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719839025

By:

Song, Xue;
Wilson, Kathleen L.;
Kagan, Jerry;
Panjabi, Sumeet

Publication type:

Article

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719837906

By:

González-Porras, José R.;
Godeau, Bertrand;
Carpenedo, Monica

Publication type:

Article

Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719827310

By:

Short, Nicholas J.;
Kantarjian, Hagop;
Ravandi, Farhad;
Daver, Naval

Publication type:

Article

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719826444

By:

Molica, Matteo;
Scalzulli, Emilia;
Colafigli, Gioia;
Foà, Robin;
Breccia, Massimo

Publication type:

Article

Immunotherapy in myeloma: how far have we come?

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718822660

By:

Franssen, Laurens E.;
Mutis, Tuna;
Lokhorst, Henk M.;
van de Donk, Niels W. C. J.

Publication type:

Article

Novel treatment approaches and future perspectives in follicular lymphoma.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718820510

By:

Sutamtewagul, Grerk;
Link, Brian K.

Publication type:

Article

A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting.

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718816699

By:

Rifkin, Robert M.;
Medhekar, Rohan;
Amirian, E. Susan;
Aguilar, Kathleen M.;
Wilson, Thomas;
Boyd, Marley;
Mezzi, Khalid;
Panjabi, Sumeet

Publication type:

Article

Epigenetic therapy combinations in acute myeloid leukemia: what are the options?

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718816698

By:

Bewersdorf, Jan Philipp;
Shallis, Rory;
Stahl, Maximilian;
Zeidan, Amer M.

Publication type:

Article